Shots: Ferring launches a new company FerGene focusing the global development and commercialization of Nadofaragene firadenovec in the US for the patients with Bacillus Calmette-Guérin (BCG) unresponsive, non-muscle invasive bladder […]readmore
Tags : Ferring
Shots: Ferring to receive the US commercialization rights for INVOcell Technology and Invo will take care of its manufacturing and supplying activities for Ferring Invo has rights to establish INVO […]readmore
Shots: Evotec to provide Ferring its discovery and development platform to develop novel therapies in fertility and gynecology and will also receive upfronts and milestone payments The multi-target and multi-year […]readmore